skip to main content
select
select
select
DateCaseTitleExpertiseCounsel
Jul 13, 2018 2018 FC 736 Eli Lilly Canada Inc. et al v. Apotex Inc. We represented Eli Lilly, Daiichi and Ube in this application relating to a patent covering Eli Lilly’s EFFIENT product.

Patents

Apr 10, 2018 Federal Court File Nos. T-598-17 through T-605-17 AbbVie Corporation et al v Samsung Bioepis Co. Ltd. We represented AbbVie in a series of eight applications under the Patented Medicines (Notice of Compliance) Regulations relating to AbbVie’s ...

Patents

Apr 9, 2018 Federal Court File No. T-1355-17 Samsung Bioepis Co., Ltd. v AbbVie Biotechnology Ltd. et al. We represented AbbVie in a patent impeachment action brought by Samsung Bioepis in relation to Samsung Bioepis’ biosimilar to AbbVIe’s ...

Patents

Feb 6, 2018 2018 FCA 32 Apotex Inc. v. Bayer Inc. We successfully represented Bayer Inc. on this important appeal, which upheld the patentee’s right to elect its damages.

Patents

Jul 24, 2017 2017 FCA 161 Idenix Pharmaceuticals, Inc. v. Gilead Pharmasset LLC.et al. We successfully represented Gilead in a patent case relating to antiviral compounds for use in the treatment of Hepatitis C. Gilead proved that Ide...

Patents

Nov 18, 2016 2016 ONSC 7151 Actavis Pharma Company v Alcon Canada Inc. et al. We obtained an order dismissing Actavis’ claims for monetary relief under the UK and Ontario Statutes of Monopolies, in an action for damage...

Patents

Sep 9, 2016 2016 FC 1013 Bayer Inc. v. Apotex Inc. and Cobalt Pharmaceuticals Company Following a six week trial, we obtained a judgment finding that Bayer’s patent covering YAZ and Yasmin birth control products was valid and i...

Patents

May 31, 2016 2016 FC 593 Janssen Inc. v. Teva Canada Limited We obtained damages in excess of $18M for Teva’s infringement of a patent covering Janssen’s LEVAQUIN product.

Patents

© 2015 Belmore Neidrauer LLP | Legal Disclaimer | Privacy Policy